| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiobesity drugs: Current and future issues
|
Hatahet, M. Ammar
|
|
2002
|
|
5 |
p. 409-415
|
artikel
|
| 2 |
Are all calories created equal? Emerging issues in weight management
|
Hollis, James H.
|
|
2005
|
|
5 |
p. 374-378
|
artikel
|
| 3 |
Are sulfonylureas passé?
|
Green, Jennifer B.
|
|
2006
|
|
5 |
p. 373-377
|
artikel
|
| 4 |
Are thiazolidinediones good or bad for the heart?
|
Taylor, Angela M.
|
|
2006
|
|
5 |
p. 378-383
|
artikel
|
| 5 |
Basal insulin therapy
|
Clore, John N.
|
|
2004
|
|
5 |
p. 342-345
|
artikel
|
| 6 |
Botanical dietary supplements and the treatment of diabetes: What is the evidence?
|
Shane-McWhorter, Laura
|
|
2005
|
|
5 |
p. 391-398
|
artikel
|
| 7 |
Cardiovascular fitness and type 2 diabetes
|
Mullooly, Cathy
|
|
2002
|
|
5 |
p. 441-447
|
artikel
|
| 8 |
Cardiovascular risk assessment in type 2 diabetes mellitus
|
Al-Ozairi, Ebaa
|
|
2006
|
|
5 |
p. 333-336
|
artikel
|
| 9 |
Clinical trials report
|
McCall, Anthony L.
|
|
2005
|
|
5 |
p. 325-328
|
artikel
|
| 10 |
Clinical trials report
|
McCall, Anthony L.
|
|
2002
|
|
5 |
p. 393-395
|
artikel
|
| 11 |
Combination therapy of dyslipidemia in non–insulin-dependent diabetes mellitus and the metabolic syndrome
|
Rembold, Christopher M.
|
|
2004
|
|
5 |
p. 330-334
|
artikel
|
| 12 |
Community-based programming to treat childhood obesity
|
Morris, Vivien
|
|
2006
|
|
5 |
p. 395-400
|
artikel
|
| 13 |
Cultural approaches to diabetes self-management programs for the Latino community
|
Millan-Ferro, Andreina
|
|
2007
|
|
5 |
p. 391-397
|
artikel
|
| 14 |
Diabetes and obesity: Medical diseases, surgical cure?
|
Aroda, Vanita R.
|
|
2004
|
|
5 |
p. 317-318
|
artikel
|
| 15 |
Diabetes self-management education and third-party reimbursement: What are the options?
|
Czarnowski-Hill, Joan V.
|
|
2007
|
|
5 |
p. 381-385
|
artikel
|
| 16 |
Does a low-fat dietary intervention reduce CVD risk?
|
Jackson, Sharon D.
|
|
2006
|
|
5 |
p. 387-388
|
artikel
|
| 17 |
Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers
|
McCall, Anthony L.
|
|
2007
|
|
5 |
p. 329-332
|
artikel
|
| 18 |
Drugs on the horizon for diabesity
|
Bailey, Clifford J.
|
|
2005
|
|
5 |
p. 353-359
|
artikel
|
| 19 |
Effectiveness of weight loss and maintenance interventions in women
|
Franz, Marion J.
|
|
2004
|
|
5 |
p. 387-393
|
artikel
|
| 20 |
Evaluation of epidemiologic evidence on the role of nutrition in the development of diabetes and its complications
|
Costacou, Tina
|
|
2005
|
|
5 |
p. 366-373
|
artikel
|
| 21 |
Exenatide and rimonabant: New treatments that may be useful in the management of diabetes and obesity
|
Green, Jennifer B.
|
|
2007
|
|
5 |
p. 369-375
|
artikel
|
| 22 |
Fitness decreases risk of all-cause and cardiovascular disease mortality whereas thinness does not
|
Franz, Marion J.
|
|
2002
|
|
5 |
p. 433-434
|
artikel
|
| 23 |
Gestational diabetes and nutritional recommendations
|
Gunderson, Erica P.
|
|
2004
|
|
5 |
p. 377-386
|
artikel
|
| 24 |
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
|
Ahrén, Bo
|
|
2007
|
|
5 |
p. 340-347
|
artikel
|
| 25 |
How do different GLP-1 mimetics differ in their actions?
|
Choukem, Simeon Pierre
|
|
2006
|
|
5 |
p. 365-372
|
artikel
|
| 26 |
How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?
|
Schwarz, Peter E. H.
|
|
2007
|
|
5 |
p. 353-362
|
artikel
|
| 27 |
Improving diabetes care and education of latinos: A challenging but important mission
|
Caballero, A. Enrique
|
|
2007
|
|
5 |
p. 321-323
|
artikel
|
| 28 |
Inpatient management of hospitalized patients with type 2 diabetes
|
Ahmann, Andrew J.
|
|
2004
|
|
5 |
p. 346-351
|
artikel
|
| 29 |
Insulin analogues: New therapies for type 2 diabetes mellitus
|
Bethel, M. Angelyn
|
|
2002
|
|
5 |
p. 403-408
|
artikel
|
| 30 |
Insulin secretagogues: Who, what, when, and how?
|
Dailey, George
|
|
2005
|
|
5 |
p. 329-332
|
artikel
|
| 31 |
Interpreting the Joslin diabetes center and joslin clinic clinical nutrition guideline for overweight and obese adults with type 2 diabetes
|
Giusti, Judy
|
|
2006
|
|
5 |
p. 405-408
|
artikel
|
| 32 |
Is glycemic variability important to assessing antidiabetes therapies?
|
Kovatchev, Boris P.
|
|
2006
|
|
5 |
p. 350-356
|
artikel
|
| 33 |
Is the metabolic syndrome a real clinical entity and should it receive drug treatment?
|
Darsow, Tamara
|
|
2006
|
|
5 |
p. 357-364
|
artikel
|
| 34 |
Is weight loss the best lifestyle intervention for type 2 diabetes?
|
Franz, Marion J.
|
|
2004
|
|
5 |
p. 361-363
|
artikel
|
| 35 |
Lactation, diabetes, and nutrition recommendations
|
Reader, Diane
|
|
2004
|
|
5 |
p. 370-376
|
artikel
|
| 36 |
Literature alert
|
|
|
2002
|
|
5 |
p. 387-389
|
artikel
|
| 37 |
Literature alert
|
|
|
2004
|
|
5 |
p. 321-323
|
artikel
|
| 38 |
Mission possible: Achieving glycemic targets with basal insulin using forced titration and pattern management
|
McCall, Anthony L.
|
|
2004
|
|
5 |
p. 327-329
|
artikel
|
| 39 |
Nutrition therapy for overweight children and adolescents with Type 2 Diabetes
|
Loghmani, Emily S.
|
|
2005
|
|
5 |
p. 385-390
|
artikel
|
| 40 |
Orlistat: Current issues for patients with type 2 diabetes
|
Mancino, Juliet M.
|
|
2006
|
|
5 |
p. 389-394
|
artikel
|
| 41 |
Pramlintide: A new tool in diabetes management
|
Want, Laura L.
|
|
2006
|
|
5 |
p. 344-349
|
artikel
|
| 42 |
Prandial hyperglycemia: Is it important to track and treat?
|
Markolf, Hanefeld
|
|
2005
|
|
5 |
p. 333-339
|
artikel
|
| 43 |
Preventing diabetes by treating aspects of the metabolic syndrome
|
Sathyaprakash, Roopa
|
|
2002
|
|
5 |
p. 416-422
|
artikel
|
| 44 |
Protein and diabetes: Much advice, little research
|
Franz, Marion J.
|
|
2002
|
|
5 |
p. 457-464
|
artikel
|
| 45 |
Pulmonary function in diabetes mellitus
|
Goldman, Michael David
|
|
2002
|
|
5 |
p. 383-384
|
artikel
|
| 46 |
Rational drug design and PPAR Agonists
|
Perfetti, Riccardo
|
|
2005
|
|
5 |
p. 340-345
|
artikel
|
| 47 |
Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes
|
Huerta, Milagros G.
|
|
2002
|
|
5 |
p. 396-402
|
artikel
|
| 48 |
Selection and education of patients for inhaled insulin
|
Bellary, Srikanth
|
|
2007
|
|
5 |
p. 363-368
|
artikel
|
| 49 |
The choice of antihypertensive drugs in patients with diabetes: Angiotensin II and beyond
|
Kalantarinia, Kambiz
|
|
2002
|
|
5 |
p. 423-430
|
artikel
|
| 50 |
The impact of nuts on diabetes and diabetes risk
|
Lovejoy, Jennifer C.
|
|
2005
|
|
5 |
p. 379-384
|
artikel
|
| 51 |
The influence of dietary fat on insulin resistance
|
Lovejoy, Jennifer C.
|
|
2002
|
|
5 |
p. 435-440
|
artikel
|
| 52 |
The role of adipose tissue as an endocrine gland
|
Hamdy, Osama
|
|
2005
|
|
5 |
p. 317-319
|
artikel
|
| 53 |
The TODAY study
|
Jackson, Sharon D.
|
|
2007
|
|
5 |
p. 379-380
|
artikel
|
| 54 |
The use of bolus insulin and advancing insulin therapy in type 2 diabetes
|
Karl, Diane M.
|
|
2004
|
|
5 |
p. 352-357
|
artikel
|
| 55 |
The use of motivational interviewing in weight loss
|
Dorsten, Brent Van
|
|
2007
|
|
5 |
p. 386-390
|
artikel
|
| 56 |
Translation of successful diabetes-related lifestyle interventions from research to practice
|
Wheeler, Madelyn L.
|
|
2005
|
|
5 |
p. 363-365
|
artikel
|
| 57 |
Utilizing the GLP-1 signaling system to treat diabetes: Sorting through the pharmacologic approaches
|
D’Alessio, David A.
|
|
2005
|
|
5 |
p. 346-352
|
artikel
|
| 58 |
Waiting to inhale: Noninjectable insulin, are we there yet?
|
Hermansen, Kjeld
|
|
2004
|
|
5 |
p. 335-341
|
artikel
|
| 59 |
Web alert
|
|
|
2002
|
|
5 |
p. 385-386
|
artikel
|
| 60 |
Web alert
|
|
|
2004
|
|
5 |
p. 319-320
|
artikel
|
| 61 |
Web alert
|
|
|
2005
|
|
5 |
p. 320-321
|
artikel
|
| 62 |
Web alert
|
|
|
2006
|
|
5 |
p. 337-338
|
artikel
|
| 63 |
Web alert
|
|
|
2007
|
|
5 |
p. 324-325
|
artikel
|
| 64 |
What can the national weight control registry teach us?
|
Daeninck, Elizabeth
|
|
2006
|
|
5 |
p. 401-404
|
artikel
|
| 65 |
What to inject when oral agents fail?
|
McCall, Anthony L.
|
|
2006
|
|
5 |
p. 341-343
|
artikel
|
| 66 |
Which basal insulin should be used in patients with type 2 diabetes mellitus?
|
Clore, John N.
|
|
2007
|
|
5 |
p. 348-352
|
artikel
|
| 67 |
Who should benefit from the use of alpha-glucosidase inhibitors?
|
Godbout, Ariane
|
|
2007
|
|
5 |
p. 333-339
|
artikel
|
| 68 |
Women, type 2 diabetes, and fracture risk
|
Schwartz, Ann V.
|
|
2004
|
|
5 |
p. 364-369
|
artikel
|
Tijdschrift beschrijving